131 related articles for article (PubMed ID: 37688488)
1. Does the use of polymethyl-methacrylate cement after intralesional curettage of giant cell tumors of appendicular bone guarantee reduced local recurrence rates? A retrospective analysis.
Colding-Rasmussen T; Horstmann PF; Jørgensen PH; Hettwer W; Hansen BH; Tierp-Wong CNE; Petersen MM
J Orthop Surg (Hong Kong); 2023; 31(3):10225536231202155. PubMed ID: 37688488
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
3. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
van der Heijden L; van de Sande MA; Dijkstra PD
Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
[TBL] [Abstract][Full Text] [Related]
4. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
5. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
6. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
7. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
9. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
[TBL] [Abstract][Full Text] [Related]
10. Recurrent giant cell tumor of long bones: analysis of surgical management.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Apr; 469(4):1181-7. PubMed ID: 20857250
[TBL] [Abstract][Full Text] [Related]
11. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis.
Zuo D; Zheng L; Sun W; Fu D; Hua Y; Cai Z
World J Surg Oncol; 2013 Jul; 11():156. PubMed ID: 23866921
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
[TBL] [Abstract][Full Text] [Related]
13. The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.
Wan R; Zhang W; Xu J; Hao P; Yang Y; Shen Y; Ding X; Qiu S
J Orthop Sci; 2012 Jul; 17(4):464-9. PubMed ID: 22526715
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
15. Giant-cell tumor of the distal forearm.
Harness NG; Mankin HJ
J Hand Surg Am; 2004 Mar; 29(2):188-93. PubMed ID: 15043887
[TBL] [Abstract][Full Text] [Related]
16. Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.
Koucheki R; Gazendam A; Perera J; Griffin A; Ferguson P; Wunder J; Tsoi K
Eur J Orthop Surg Traumatol; 2023 May; 33(4):759-772. PubMed ID: 35377078
[TBL] [Abstract][Full Text] [Related]
17. Giant cell tumor of bone: risk factors for recurrence.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
[TBL] [Abstract][Full Text] [Related]
18. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
19. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of low-grade chondrosarcoma involving the appendicular skeleton: long-term functional and oncological outcomes.
Shemesh SS; Pretell-Mazzini J; Quartin PAJ; Rutenberg TF; Conway SA
Arch Orthop Trauma Surg; 2019 Dec; 139(12):1659-1666. PubMed ID: 31020410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
